
Base editing: What is it and what does it mean for healthcare?
This week, we take an in-depth look at the genome-editing technology that has been making headlines worldwide

Cancer therapy involving genome editing cures another child’s leukaemia
We look at a new type of CAR-T cell therapy that, in the world’s first use, has cured a child patient’s leukaemia

Genomics on the horizon: Three predictions for 2023
To kick off the new year, we look at three areas of genomics research and advancement to watch out for in 2023 and beyond

Looking back: Genomics in 2022 (part one)
In the first of our two-part round-up of 2022, we look back at some of this year's most exciting clinical developments in genomics

How accurate are genomic tests?
We outline five key things to consider when answering the common patient question, “How accurate is this genomic test?”

Marvel star goes public on his APOE genetic link to Alzheimer's
Chris Hemsworth recently revealed his APOE4 status, which he discovered while filming a documentary on living better for longer

How can genomics combat doxorubicin-induced cardiotoxicity?
This week, we examine the role that genomics could play in reducing the number of child cancer patients who experience doxorubicin-induced cardiotoxicity

Ambitious health study recruiting 1 in 10 UK adults
The Our Future Health study hopes to address the diversity problem in genomic datasets as it continues its recruitment of five million volunteers

The NHS's new strategy for genomics: Five key takeaways
We look at the new ‘Accelerating genomic medicine in the NHS’ report and what it means for healthcare professionals

Achromatopsia gene therapy partially restores children’s colour vision
A new gene therapy for achromatopsia has partially restored colour vision in two children, according to new research

Reducing stroke risk with a genetic test
NHS Tayside introduces UK's first routine genetic test for stroke patients, estimated to bring improved outcomes to thousands of patients each year

Bringing whole genome sequencing to primary care
We explore how first-contact care and genomic testing could align, and the pivotal part this combination could play in the future